Drug search by name

Venlafaxine Extended-Release Capsules and Weight loss

Result of checking the interaction of drug Venlafaxine Extended-Release Capsules and disease Weight loss for safety when used together.

Check result:

Venlafaxine Extended-Release Capsules <> Weight loss

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of venlafaxine may occasionally cause significant, dose-dependent weight loss, which may be undesirable in patients suffering from anorexia, malnutrition or excessive weight loss. The loss of at least 5% of body weight occurred in 6% to 7% of treated patients in premarketing studies, compared to 1% to 2% for placebo. Anorexia may occur in approximately 10% of patients. Weight change should be monitored during therapy if venlafaxine is used in malnourished or underweight patients.

References:

"Product Information. Effexor (venlafaxine)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
Cunningham LA, Borison RL, Carman JS, Chouinard G, Crowder JE, Diamond BI, Fischer DE, Hearst E "A comparison of venlafaxine, trazodone, and placebo in major depression." J Clin Psychopharmacol 14 (1994): 99-106

Venlafaxine Extended-Release Capsules

Generic Name: venlafaxine

Brand Name: Effexor XR, Effexor

Synonyms: Venlafaxine

What is Venlafaxine Extended-Release Capsules?